EW vs FOLD · P/E 47, rev $1.39B vs rev $528.3M
Edwards Lifesciences Corp (EW) versus Amicus Therapeutics Inc (FOLD) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
EW currently screens at market cap $49.91B and trailing P/E 46.9. FOLD currently screens at market cap $1.80B.
Not investment advice. Open the EW and FOLD stock pages for the full models.
Not investment advice.